Abstract
Introduction
Uterine leiomyosarcomas (ULMS) are rare neoplasms, representing 1 in 200 to 800 smooth muscle tumours or ~1% of all malignancies of the uterus [1] . Although the reported 5-year ULMS survival rates are variable, these tumours are clinically aggressive and have a high risk of recurrence and overall poor prognosis [2] . The cause or the molecular basis of human ULMS is largely unknown. While it was believed that most ULMS could arise de novo, some reports suggest that ULMS was progressive from pre-existing uterine leiomyomas (ULM) [3, 4] . However, the conclusive evidence documenting the transformation of ULM to ULMS is lacking in human beings and it is thought that the incidence of transformation is Ͻ0.1% [5] .
HMGA2, a high-mobility-group AT-hook (HMGA) protein, is considered to function as an oncogene strongly associated with many malignant epithelial and mesenchymal neoplasms [6] . It has three AT-hook DNA binding domains, through which HMGA2 binds to AT-rich sequences in the minor groove of the DNA helix. HMGA2 is expressed in embryonic tissue but not in most adult tissues [7, 8] . HMGA2 is overexpressed in ULM due to chromosomal 12q15 changes [9] [10] [11] [12] . Overexpression of HMGA2 in ULMS has been suggested, but not fully investigated [4, 13] . HMGA2 is an important regulator of cell growth, differentiation, apoptosis and transformation [14] . New evidence suggest that dysregulation of microRNAs (miRNAs) may play a central role in tumour development [15] . Members of the let-7 miRNA family function as tumour suppressors through specific repression of its target gene, particularly of HMGA2 expression in some tumour cells both in vivo and in vitro [4, 16, 17] . The biological importance of molecular pairing of HMGA2::let-7 was further illustrated by the demonstration that repression of HMGA2 by let-7s impairs tumour cell proliferation in many different tumour types, including ULM [4, [16] [17] [18] [19] . It 
Primers and antibodies
Primers from HMGA2 and its alternative spliced transcripts were reported previously [19] . Primers 
Let-7c miRNAs in situ hybridization
The hybridization system and probes, miRCURY LNA, Let-7c, and U6, were purchased from Exiqon (Vedbaek, Denmark). The detailed procedure for in situ hybridization was followed as per manufacturer's protocol [20] . In brief, 4- [19] . The abundances of cDNA products were detected by qRT-PCR and were normalized by the internal control products of U6 and ␣-Actin.
Immunohistochemistry
The TMA blocks from FFPE tissues were sectioned at 4 microns. After deparaffinization and antigen retrieval, all immunohistochemical staining was performed on a Ventana Nexus automated system. (Fig.1B) Fig. 1A) . Fig. 2A) . [12, 21] (Fig. 3A) . In addition, HMGA2 cryptic transcripts c, d and f showed moderate levels in these cell lines (Fig. 3A) . Fig. 1 HMGA2 and 
Western blot analysis

Results
HMGA2 and let-7 expression in ULMS
In those five cases with RT-PCR data, higher levels of HMGA2 mRNA in ULMS-32 and -34 were accompanied by lower levels of let-7s (
Correlation analyses were performed between HMGA2 expression and tumour size, tumour markers of Ki-67, P53, ER␣ and PR-A. We found a weak positive correlation of HMGA2 expression and tumour sizes (r ϭ 0.35). There was not significant correlation of HMGA2 with other immunomarkers.
Translational regulation of HMGA2 by let-7s in ULMS cell lines
To test whether endogenous let-7s play a major role in repression of HMGA2 in ULMS, we selected three ULMS cell lines for the study. We first examined HMGA2 and its cryptic transcript (isoforms)
expression in these cell lines by RT-PCR analysis. Since HMGA2a and its cryptic transcripts can be induced in primary
In contrast, expression of let-7s was quite low in comparison to normal myometrium and ULM based on a semi-quantitative analysis (Fig. 3B). Let-7c and f were the most abundant transcripts of let-7 family in these cell lines. To test the role of let-7s in repression of HMGA2 after transcription and translation, we transfected the exogenous let-7c mimic
Fig. 2 Semi-quantitative RT-PCR (upper panel) and Western blot (lower panel) analyses of HMGA2 and some let-7 family members in fresh frozen tissue samples of five ULMS. (A) HMGA2 mRNA was detectable in all 5 ULMS. One matched myometrium (MM) and one leiomyoma (ULM) were used as HMGA2 negative and positive control, respectively. Actin was used as loading control. Among let-7 members, let-7c was relatively higher than others in all ULMS. U6 was used as small RNA loading control. Western blot analysis of HMGA2 was examined in 4 ULMS (bottom). (B) Photographs illustrate gross appearance of a ULMS cross-section in case ULMS-34 and the corresponding karyotype (inserts with chromosome alterations) obtained in two different tumour regions. and let-7 inhibitor in all cell lines. In untreated cell lines (controls), low levels of endogenous let-7s seemed not enough to destabilize
HMGA2a and other cryptic mRNA (Fig. 3A and B ), but were sufficient to repress HMGA2 translation (Fig. 3D, control lanes) . When applying 40 pmol of exogenous let-7c, a significant reduction of HMGA2a, c, and f mRNAs (Fig. 3C) was observed, and a complete repression of HMGA2 protein was evident by a Western blot analysis (Fig. 3D, let-7c channel) . When the cells treated with exogenous let-7 inhibitor (which can completely block endogenous let-7s), up to fivefold increases of HMGA2 protein were observed in comparison to the untreated cells (Fig. 3D) . The findings further supported that HMGA2 repression by let-7s is specific regulatory mechanism for HMGA2 expression in uterine leiomyosarcoma cells. Fig. 3C and D, we counted for the tumour growth rates at days 1, 2 and 3 in all three ULMS cell lines (Fig.  4) (Fig. 4) . The later findings suggested that let-7 mediated tumour growth in ULMS is not solely through repression of HMGA2, and other let-7 target genes may be involved [22] (Fig. 4) . changes involving chromosomal 12q13-15 region in leiomyosarcomas had been occasionally reported through traditional karyotype [23] and comparative genomic hybridization (CGH) analysis [4] [17, 18, 24, 25] . Particularly, it has been found that dysregulation of let-7s is associated with HMGA2 expression in ULM and related to cell proliferation [17] 
Repression of HMGA2 inhibited ULMS cell growth
To test whether HMGA2 in ULMS cell lines plays a role in regulation of tumour growth rate, we examined the tumour cell proliferation by introducing exogenous let-7 and let-7 inhibitor, respectively. The cells were treated in triplicate with Block-iT (control), let-7c and let-7 inhibitor. Repression of HMGA2 by let-7c and induction of HMGA2 overexpression by let-7 inhibitor were validated as shown in
. Starting from day 2 (48 hrs), cells treated with let-7c had significantly lower rates of tumour cell growth than control (P Ͻ 0.05). The differential growth rates were even wider at day 3 (72 hrs). Particularly, the growth rates in tumour cells treated with let-7 inhibitor were significantly higher than those in let-7c treated cells (P Ͻ 0.05), but at least two cell lines lower than those in control groups
Discussion
ULMS usually have very complicated cytogenetic alterations involving many different chromosomal regions. Cytogenetic
in ULMS cell lines SK-LMS-1 (A), SK-UT-1 (B) and SK-UT-1b (C
